Market Overview - Major U.S. index futures are showing positive movement, with Dow futures up 0.16%, S&P 500 futures up 0.24%, and Nasdaq futures up 0.40% [1] Technology Sector - Most technology stocks are rising, with Nvidia up over 1.5% in pre-market trading, and AMD and Advanced Micro Devices both up over 1% [2] - Nvidia reportedly placed an order for 300,000 H20 chips from TSMC, contributing to its pre-market increase of over 1.5% [4] Chinese Stocks - Several Chinese stocks are experiencing significant gains, including Li Auto up over 4%, GDS Holdings up over 3%, and Miniso and NIO both up over 1% [3] Biotechnology Sector - Sarepta Therapeutics saw a pre-market surge of over 40% after the FDA authorized the resumption of its gene therapy Elevidys for treating Duchenne muscular dystrophy (DMD) [5] Apple Inc. - Apple announced the closure of its first direct retail store in China, located in Dalian, set to close on August 9, 2025, due to the departure of multiple retailers from the shopping center [6] Tesla Inc. - Tesla's Shanghai energy storage superfactory has officially produced its 1,000th Megapack energy storage system, which will be shipped to Europe [7] Automotive Industry - Ford has signed a new $3 billion revolving credit agreement, with a borrowing term lasting until July 28, 2026 [8] - Stellantis reported a 13% year-over-year decline in net revenue for the first half of 2025, totaling €74.3 billion, primarily impacted by declines in North America and Europe, resulting in a net loss of €2.3 billion compared to a net profit of €5.6 billion in the same period last year [9]

Group 1 - Advanced Micro Devices (AMD) reported a revenue that exceeded expectations for the first quarter and provided a second-quarter revenue guidance that also surpassed forecasts, resulting in a stock increase of approximately 2% [1] - Super Micro Computer (Supermicro) experienced a decline of about 4% in its stock price after the company lowered its full-year sales forecast and acknowledged the impact of tariffs imposed by former President Trump [1] - Novo Nordisk's stock rose approximately 6% as analysts from JPMorgan noted that the company's decision to lower its earnings guidance for the year has already been reflected in its stock price [1]